FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Honoring Service Beyond the Uniform
November 19, 2024

See how MQA streamlines licensure for those who have sacrificed the most and explore veteran stories, military licensure trends, and more! Continue reading


The MQA FY 23-24 Annual Report and Long-Range Plan is Here!
November 1, 2024

Check out the report on the MQA Reports and Publications page to see how MQA is advancing its mission to make Florida the healthiest state in the nation. Continue reading